Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Milagros Balbín

Showing results (1-10 of 35) with videos related to

Pageof 4
Sort By:
Kidney International|February 19, 2002
Nitric oxide regulates matrix metalloprotease-13 expression and activity in endotheliumCarlos Zaragoza, Milagros Balbín, Carlos López-Otín, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|May 11, 2005
Expression patterns of matrix metalloproteinases and vascular endothelial growth factor during epiphyseal ossificationJesús Alvarez, Lorena Costales, Rosa Serra, et al.
Molecular Pharmacology|September 19, 2002
Activation of the mitogen activated protein kinase extracellular signal-regulated kinase 1 and 2 by the nitric oxide-cGMP-cGMP-dependent protein kinase axis regulates the expression of matrix metalloproteinase 13 in vascular endothelial cellsCarlos Zaragoza, Estrella Soria, Esther López, et al.
Advances in Experimental Medicine and Biology|August 12, 2003
Matrix metalloproteinases and tumor progressionJosé M P Freije, Milagros Balbín, Alberto M Pendás, et al.
Head & Neck|February 10, 2012
Medullary thyroid carcinoma and 2q37 deletion in a patient with nevoid basal cell carcinoma syndrome: clinical description and genetic analysisAndrés Coca-Pelaz, Jose Luis Llorente-Pendás, Jorge García-Martínez, et al.
Cancer Biomarkers : Section a of Disease Markers|December 30, 2017
TP53 p.R72P genotype is a marker of poor prognosis in lung cancerMirko Peter Neumann, María Victoria González, Ana S Pitiot, et al.
Otolaryngology--Head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery|April 28, 2009
Chromosomal changes in sporadic and familial head and neck paragangliomasMaría A Sevilla, Mario A Hermsen, Marjan M Weiss, et al.
Cellular Oncology : the Official Journal of the International Society for Cellular Oncology|March 9, 2010
Relevance of germline mutation screening in both familial and sporadic head and neck paraganglioma for early diagnosis and clinical managementMario A Hermsen, María A Sevilla, José Luis Llorente, et al.
The Journal of Clinical Endocrinology and Metabolism|September 15, 2012
Identification of a signaling axis HIF-1α/microRNA-210/ISCU independent of SDH mutation that defines a subgroup of head and neck paragangliomasAnna Merlo, Sandra Bernaldo de Quiros, Pablo Secades, et al.
Clinical Immunology (Orlando, Fla.)|October 21, 2022
Mapping the genetic features of T-ALL cases through simplified NGS approachJosé María García-Aznar, Sara Alonso, David De Uña Iglesias, et al.
Pageof 4

Showing results (1-10 of 35) with videos related to

Sort By:
Pageof 4
Kidney International|February 19, 2002
Nitric oxide regulates matrix metalloprotease-13 expression and activity in endotheliumCarlos Zaragoza, Milagros Balbín, Carlos López-Otín, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|May 11, 2005
Expression patterns of matrix metalloproteinases and vascular endothelial growth factor during epiphyseal ossificationJesús Alvarez, Lorena Costales, Rosa Serra, et al.
Molecular Pharmacology|September 19, 2002
Activation of the mitogen activated protein kinase extracellular signal-regulated kinase 1 and 2 by the nitric oxide-cGMP-cGMP-dependent protein kinase axis regulates the expression of matrix metalloproteinase 13 in vascular endothelial cellsCarlos Zaragoza, Estrella Soria, Esther López, et al.
Advances in Experimental Medicine and Biology|August 12, 2003
Matrix metalloproteinases and tumor progressionJosé M P Freije, Milagros Balbín, Alberto M Pendás, et al.
Head & Neck|February 10, 2012
Medullary thyroid carcinoma and 2q37 deletion in a patient with nevoid basal cell carcinoma syndrome: clinical description and genetic analysisAndrés Coca-Pelaz, Jose Luis Llorente-Pendás, Jorge García-Martínez, et al.
Cancer Biomarkers : Section a of Disease Markers|December 30, 2017
TP53 p.R72P genotype is a marker of poor prognosis in lung cancerMirko Peter Neumann, María Victoria González, Ana S Pitiot, et al.
Otolaryngology--Head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery|April 28, 2009
Chromosomal changes in sporadic and familial head and neck paragangliomasMaría A Sevilla, Mario A Hermsen, Marjan M Weiss, et al.
Cellular Oncology : the Official Journal of the International Society for Cellular Oncology|March 9, 2010
Relevance of germline mutation screening in both familial and sporadic head and neck paraganglioma for early diagnosis and clinical managementMario A Hermsen, María A Sevilla, José Luis Llorente, et al.
The Journal of Clinical Endocrinology and Metabolism|September 15, 2012
Identification of a signaling axis HIF-1α/microRNA-210/ISCU independent of SDH mutation that defines a subgroup of head and neck paragangliomasAnna Merlo, Sandra Bernaldo de Quiros, Pablo Secades, et al.
Clinical Immunology (Orlando, Fla.)|October 21, 2022
Mapping the genetic features of T-ALL cases through simplified NGS approachJosé María García-Aznar, Sara Alonso, David De Uña Iglesias, et al.
Pageof 4